The biology, pathology and therapeutic use of prostaglandins in the eye
@article{Toris2011TheBP, title={The biology, pathology and therapeutic use of prostaglandins in the eye}, author={Carol B. Toris and Vikas Gulati}, journal={Clinical Lipidology}, year={2011}, volume={6}, pages={577 - 591} }
Abstract Prostaglandins (PGs) are ubiquitous compounds found throughout the body, including the eye. They are involved in a variety of ocular functions, two of which are intraocular pressure (IOP) regulation and mediation of inflammation. Currently, PG analogs are the mainstay of topical IOP lowering therapy for glaucoma. The IOP effects of PGs are mediated by their actions on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases, thereby facilitating the outflow of…
9 Citations
Mechanisms and Treatment of Light-Induced Retinal Degeneration-Associated Inflammation: Insights from Biochemical Profiling of the Aqueous Humor
- BiologyInternational journal of molecular sciences
- 2020
Findings provide a rationale for using a combination of mitochondria-targeted antioxidant and cyclooxygenase inhibitor for the treatment of inflammatory components of retinal degenerative diseases.
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study
- Medicine, BiologyBMC Ophthalmology
- 2014
In both PACG and PACG, there were no significant differences in the levels of MMPs and TIMPs between patients on prostaglandin analogues and those not, and the MMP-2/TIMP-2 ratio was highest in PACG.
Tear biomarkers in latanoprost and bimatoprost treated eyes
- Medicine, BiologyPloS one
- 2018
Differential cytokine and MMP expression indicates differential signalling pathways mediating different cellular effects (evident as clinical and side effects) with the two drugs which can be explored further.
The Ocular and Systemic Adverse Effects of Topical 0.1% Diclofenac in Healthy Cats
- Medicine, Biology
- 2013
Pharmacokinetic analysis showed that accumulation occurs with repeated dosing, and topical 0.1% diclofenac treatment did not have any significant effect on hepatic or renal function, other than reduction GFR in the second phase of the study.
Concentrations of PGE2 and TXB2 in the Eyes of Mice with Disseminated Acanthamoebiasis
- Biology, MedicinePathogens
- 2022
This study confirmed the existence of an inflammatory process in the eyes of immunocompetent and Immunocompromised mice infected with Acanthamoeba spp.
Role of the Non-enzymatic Metabolite of Eicosapentaenoic Acid, 5-epi-5-F3t-Isoprostane in the Regulation of [3H]d-Aspartate Release in Isolated Bovine Retina
- Biology, MedicineNeurochemical Research
- 2014
5-epi-5-F3t-IsoP attenuates K+-induced [3H]d-aspartate release in a concentration-dependent manner by mechanisms that are partially dependent on activation of pre-junctional prostanoid EP1-receptors.
Advances in hair growth
- MedicineFaculty reviews
- 2022
Emerging evidence that has advanced understanding of hair growth and new insights into the pathogenesis and mechanism of hair loss are reviewed to provide a context for outlining current and emerging therapies.
Preparation and Chiral HPLC Separation of the Enantiomeric Forms of Natural Prostaglandins
- Chemistry
- 2020
Four enantiomeric forms of natural prostaglandins, ent-PGF2α ((−)-1), ent-PGE2 ((+)-2) ent-PGF1α ((−)-3), and ent-PGE1 ((+)-4) have been synthetized in gram scale by Corey synthesis used in the…
References
SHOWING 1-10 OF 170 REFERENCES
Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.
- Biology, MedicineSurvey of ophthalmology
- 2008
Prostaglandin analogs in the treatment of glaucoma.
- MedicineSeminars in ophthalmology
- 1999
Prostaglandin analogs have a different mechanism of action than other ocular hypotensives, and act primarily by increasing uveoscleral outflow, and have a substantial additive effect when used with agents that reduce aqueous production or that increase trabecular outflow facility.
Prostaglandin analogues in the anterior eye: their pressure lowering action and side effects.
- MedicineExperimental eye research
- 2009
Prostaglandins. Old concepts and new perspectives.
- MedicineArchives of ophthalmology
- 1987
Substantial evidence is provided that the intraocular pressure (IOP)-lowering effect of topically applied prostaglandin F2α(PGF2α) results from an increase in uveoscleral outflow.
Release of prostaglandins in ocular inflammation in the rabbit.
- MedicineNature: New biology
- 1972
Uveitis was induced by a single intravitreal injection of a sterile solution of crystallized bovine serum albumin (British Drug Houses) and fine filaments were seen in the anterior chamber when uveitis occurred in the test eye.
Effects of prostaglandins on the aqueous humor outflow pathways.
- Biology, MedicineSurvey of ophthalmology
- 2002
Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids.
- BiologySurvey of ophthalmology
- 1997
The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
- Medicine, BiologyInvestigative ophthalmology & visual science
- 2005
The prostanoid FP receptor plays a crucial role in the mechanism of early IOP lowering of all commercially available prostaglandin analogues as well as presumed functional uveoscleral outflow pathways in FPKO mice.
Metabolism of arachidonic acid in the retina and retinal pigment epithelium: biological effects of oxygenated metabolites of arachidonic acid.
- Biology, MedicineProgress in clinical and biological research
- 1989
Evidence is presented indicating that eicosanoids can also be involved in retinal neurotransmission and cell to cell interaction, and an involvement of 5-lipoxygenase metabolites in the initial steps of ROS phagocytosis is presented.
Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds.
- MedicineExperimental eye research
- 1984